Figure 3
Survival analysis. Overall survival (A, n = 71), event-free survival (B, n = 71), relapse-free survival (C, n = 67), and relapse-free survival according to MRD2 at the level of 0.1% (D, n = 49).
Survival analysis. Overall survival (A, n = 71), event-free survival (B, n = 71), relapse-free survival (C, n = 67), and relapse-free survival according to MRD2 at the level of 0.1% (D, n = 49).
